Literature DB >> 28050781

The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.

Shoichiro Hikami1, Atsushi Shiozaki2, Maki Kitagawa-Juge1, Daisuke Ichikawa1, Toshiyuki Kosuga1, Hirotaka Konishi1, Shuhei Komatsu1, Hitoshi Fujiwara1, Kazuma Okamoto1, Eigo Otsuji1.   

Abstract

BACKGROUND: The inhibitor of apoptosis protein (IAP) family are reported to play important roles in cancer cells evading apoptosis. However, the significance of their expression in human esophageal squamous cell carcinoma (ESCC) cells remains uncertain. AIMS: The present study aimed to investigate the role of the IAP family members in tumor necrosis factor-α (TNF-α)-induced apoptosis of human ESCC cells.
METHODS: Five human ESCC cell lines were pretreated with TNF-α, cycloheximide (CHX, protein synthesis inhibitor), epoxomicin (proteasome inhibitor). Apoptosis assay and protein study with Western blot testing were conducted. Knockdown experiments with IAP siRNA were conducted, and the effect on cell apoptosis was analyzed.
RESULTS: Significant apoptosis was induced in five ESCC cell lines by TNF-α plus CHX stimulation, but not when treated with TNF-α or CHX alone. The protein expression levels of cIAP1 and XIAP were decreased by treatment with TNF-α in the presence of CHX, and the degree of cIAP1 and XIAP expression decrease was correlated with sensitivity to TNF-α plus CHX-induced apoptosis. Epoxomicin suppressed TNF-α plus CHX-induced degradation of survivin, cIAP1, and XIAP, in addition to apoptosis. A caspase inhibitor (z-VAD-fmk) suppressed TNF-α plus CHX-induced apoptosis, but did not suppress degradation of survivin, cIAP1, and XIAP. Furthermore, cIAP1 or XIAP siRNA transfected cells underwent apoptosis in response to treatment with TNF-α alone. Double knockdown of both genes resulted in further increased apoptosis.
CONCLUSION: cIAP1 and XIAP play an essential role in the resistance of ESCC cells against apoptosis.

Entities:  

Keywords:  Apoptosis; Cycloheximide; Esophageal cancer; IAP; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 28050781     DOI: 10.1007/s10620-016-4430-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling.

Authors:  Yongge Zhao; Dietrich B Conze; John A Hanover; Jonathan D Ashwell
Journal:  J Biol Chem       Date:  2007-01-12       Impact factor: 5.157

2.  Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2.

Authors:  Yoko Tanimura; Toshio Kokuryo; Nobuyuki Tsunoda; Yukiko Yamazaki; Koji Oda; Yuji Nimura; Naing Naing Mon; Pengyu Huang; Yasuni Nakanuma; Min-Fu Chen; Yi-Yin Jan; Ta-Sen Yeh; Cheng-Taug Chiu; Ling-Ling Hsieh; Michinari Hamaguchi
Journal:  Cancer Lett       Date:  2005-03-10       Impact factor: 8.679

3.  High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy.

Authors:  Hongxia Zhu; Qifeng Wang; Chenfei Hu; Wencheng Zhang; Lanping Quan; Mei Liu; Ningzhi Xu; Zefen Xiao
Journal:  Tumour Biol       Date:  2011-08-09

4.  Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.

Authors:  Sheng-Tang Wu; Guang-Huan Sun; Chih-Ying Hsu; Chang-Shuo Huang; Yu-Hsin Wu; Hsiao-Hsien Wang; Kuang-Hui Sun
Journal:  Exp Biol Med (Maywood)       Date:  2011-08-19

5.  Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.

Authors:  Z Liu; C Sun; E T Olejniczak; R P Meadows; S F Betz; T Oost; J Herrmann; J C Wu; S W Fesik
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

6.  Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

Authors:  I Tamm; S M Kornblau; H Segall; S Krajewski; K Welsh; S Kitada; D A Scudiero; G Tudor; Y H Qui; A Monks; M Andreeff; J C Reed
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

7.  Tumor necrosis factor-α-induced apoptosis of gastric cancer MKN28 cells: accelerated degradation of the inhibitor of apoptosis family members.

Authors:  Maki Kitagawa; Atsushi Shiozaki; Daisuke Ichikawa; Shingo Nakashima; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Arch Biochem Biophys       Date:  2014-12-13       Impact factor: 4.013

8.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

Authors:  James E Vince; W Wei-Lynn Wong; Nufail Khan; Rebecca Feltham; Diep Chau; Afsar U Ahmed; Christopher A Benetatos; Srinivas K Chunduru; Stephen M Condon; Mark McKinlay; Robert Brink; Martin Leverkus; Vinay Tergaonkar; Pascal Schneider; Bernard A Callus; Frank Koentgen; David L Vaux; John Silke
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

Review 9.  The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.

Authors:  Boaz Nachmias; Yaqoub Ashhab; Dina Ben-Yehuda
Journal:  Semin Cancer Biol       Date:  2004-08       Impact factor: 15.707

Review 10.  IAPs: guardians of RIPK1.

Authors:  M Darding; P Meier
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

View more
  3 in total

Review 1.  Lung carcinogenesis and fibrosis taken together: just coincidence?

Authors:  Ioanna Giopanou; Kristina A M Arendt; Georgios T Stathopoulos
Journal:  Curr Opin Pulm Med       Date:  2017-07       Impact factor: 3.155

2.  Downregulation of Smac attenuates H2O2-induced apoptosis via endoplasmic reticulum stress in human lens epithelial cells.

Authors:  Kong De-Qian; Liu Yue; Li Li; Zheng Guangying
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma.

Authors:  Toshiyuki Kobayashi; Atsushi Shiozaki; Yoshito Nako; Daisuke Ichikawa; Toshiyuki Kosuga; Katsutoshi Shoda; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Yoshinori Marunaka; Eigo Otsuji
Journal:  Oncotarget       Date:  2018-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.